Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-10-23

Clinical Trial Update: Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study [Phase 2]

View source ↗

Summary

The REPLACING Study, a Phase 2 trial evaluating robotic bronchoscopy with cone-beam CT and indocyanine green for removing lung lesions in Stage I non-small cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Lung | Phase 2 | Status: WITHDRAWN